We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Prof
Iain L C
Chapple
i.l.c.chapple@bham.ac.uk
Dr
Naomi
Hubber
N.A.Campton@bham.ac.uk
Renal failureDiabetes mellitus
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
The prevalence of chronic non-communicable diseases (CNCD) is increasing globally and their impact on the global disease burden and healthcare economy is substantial. Severe CKD is a major global public health problem due to the costs of providing renal support such as dialysis. Early identification and successful monitoring is key to providing effective CKD treatments. This study is examining whether monitoring of creatinine (a protein in the blood that is a useful marker of kidney function) using a point of care testing device (a finger-prick) is as good as a full blood test in assessing kidney function. The second point of care machine (DCA Vantage) tests for HbA1C levels which will screen for diabetes. If the DCA Vantage shows that finger prick tests accurately correlate to our existing laboratory methods, POC testing may be utilised chairside, producing immediate results, therefore allowing more streamlined patient care and earlier intervention. The study will recruit patients from the Renal Medicine Department and the Diabetes Unit at the Queen Elizabeth Hospital in Birmingham, respectively.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Qualitative;
You can take part if:
You may not be able to take part if:
The exclusion criteria is as follows a. Patient under 16 years old b. Patient is unable or unwilling to provide valid informed consent c. Patients with comorbid disease state that would produce unreliable results in the opinion of the investigator.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by University of Birmingham and funded by Oral and Dental Research Trust .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 32717
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
